• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    The present application relates to a bioreactor device equipped with a microfluidic or nanofluidic structure comprising a biological sample-extraction chamber, a reaction chamber, and a microfluidic or nanofluidic structure for transferring the biological sample from the biological sample-extraction chamber to the reaction chamber. The microfluidic or nanofluidic structure comprises a biological sample channel and a reaction liquid injection channel. The biological sample-extraction chamber and the reaction chamber are in fluid communication with each other via the biological sample channel, and the reaction liquid is injected into the reaction chamber through the reaction liquid injection channel. The microfluidic or nanofluidic structure further comprises a first valve for blocking or opening the biological sample channel and a second valve for blocking or opening the reaction liquid injection channel. The bioreactor device of the present application can accurately quantify the biological sample, and transfer it into the reaction chamber sufficiently and efficiently, thereby simplifying the experimental processes, improving the experimental efficiency, and reducing the possibility of contamination when the biological samples are transferred.
    公开号:EP3683297A1
    申请号:EP19848860.3
    申请日:2019-01-03
    公开日:2020-07-22
    发明作者:Jiachang YU；Jia Zhang；Quan XU
    申请人:Igenesis Shanghai Co Ltd；
    IPC主号:G01N35-00
    专利说明:
    [0001] The present application is based on the Chinese invention application with the application number of 201811443084.0 , which is titled "A BIOREACTOR DEVICE EQUIPPED WITH A MICROFLUIDIC OR NANOFLUIDIC STRUCTURE" and filed on November 29, 2018, and claim the priority right thereof. FIELD OF THE INVENTION
    [0002] The present application relates to the technical fields of biochemistry and molecular biology, and more particularly relates to a bioreactor device equipped with a microfluidic or nanofluidic structure. BACKGROUND OF THE INVETNION
    [0003] With the change of medical methods and continuous development of individualized medication, there is an urgent need in the field of medical examination to develop a rapid and accurate detection means. In this regard, molecular detection exhibits unique advantages. The basis of molecular detection is to detect nucleic acids (DNA and RNA) in a molecular level, by analyzing the genes and the expression products thereof from tissue cells, a hair, an anticoagulant, a dry blood trace or a formaldehyde-fixed or paraffin-embedded tissue from a person to be detected. As a result, the molecular detection is able to accurately detect a disease once the disease occurs or even before any symptoms, changes of signs or biochemistry occurs.
    [0004] At present, molecular detection technologies mainly include nucleic acid hybridization, polymerase chain reaction (PCR) and biochip technology and the like. Molecular detection products are mainly used in various clinical departments to detect tumor, infection, genetics, prenatal screening and the like, and also used in physical examination centers, technical service centers, third-party testing institutions and rapid micro-testing markets. Presently, detection means for blood routine, cytology, pathology and immunology are all developing towards automation, integration and standardization. However, due to the technical complexity of molecular detection, there are very few fully automated instruments platforms that handle in a "sample-to-result" model. Alternatively, many technical problems are difficult to solve. For example, the centrifugal column method or the magnetic bead method used to extract nucleic acid in biotechnology generally comprise four steps of cleaving, binding, rinsing, and eluting as well as the subsequent detection steps such as nucleic acid hybridization, polymerase chain reaction (PCR), a biochip and the like. As a result, it is very difficult to realize a fully automated instrument in a "sample-to-result" model. In the prior art, the active ingredients are usually transferred manually when transferring of active ingredients between the steps. In other words, the raw materials or intermediate products are transferred by a person between the sequential steps or the reaction vessels for carrying out the sequential steps. Obviously, it is complicated, time-consuming and laborious for transferring the materials manually as adopted in the prior art. More importantly, the whole operations even are easy to cause contamination and influence the purities of the extracts. Furthermore, the materials are difficult to be fully mixed and efficiently transferred, which influences the experimental results. Therefore, due to the technical complexity of molecular detection, there are very few fully automated instruments platforms that handle in a "sample-to-result" model. Alternatively, many technical problems are difficult to solve. In order to realize full and efficient transferring of the materials between different steps, it is necessary to comprehensively consider the structures and functions of the consumables and experimental devices. Thus, it is possible to avoid the problems existing in the prior art of high-cost, low sensitivity, complicated structures, over-complexity to operate the related detection devices and the like.
    [0005] Therefore, there is an urgent need in the field to develop a bioreactor device which has a simple structure and is convenient to operate. SUMMARY OF THE INVENTION
    [0006] In view of the defects existing in the prior art, a technical problem solved by the present invention is to provide a bioreactor device equipped with a microfluidic or nanofluidic structure, which connects a biological sample-extraction chamber, a metering chamber and a reaction chamber. In addition, the biological sample (e.g., protein, nucleic acid) in the biological sample-extraction chamber is accurately quantified by the microfluidic or nanofluidic structure, and sufficiently and efficiently transferred to the reaction chamber. Therefore, the experimental processes are simplified, and the experimental efficiency is improved. Furthermore, when the biological sample is transferred, the risk of contamination is reduced.
    [0007] Another technical problem to be solved by the present invention is to provide a bioreactor device equipped with a microfluidic or nanofluidic structure, which has a simple structure and is convenient to operate. Furthermore, the bioreactor device can effectively simplify the equipment used in conjunction therewith.
    [0008] In order to achieve the above objects, the present application provides the following technical solutions.
    [0009] In a first aspect, the present application provides a bioreactor device equipped with a microfluidic or nanofluidic structure, wherein the bioreactor device comprises: a biological sample-extraction chamber for providing a biological sample to be used in a biological reaction, comprising a liquid delivery tip disposed in the biological sample-extraction chamber; a reaction chamber for causing the biological sample to biologically react with a reaction liquid to be biologically reacted with the biological sample; and a microfluidic or nanofluidic structure for transferring the biological sample from the biological sample-extraction chamber to the reaction chamber; wherein the microfluidic or nanofluidic structure comprises a biological sample channel and a reaction liquid injection channel; wherein the biological sample-extraction chamber and the reaction chamber are in fluid communication with each other via the biological sample channel, and the reaction liquid is injected into the reaction chamber through the reaction liquid injection channel; wherein the microfluidic or nanofluidic structure further comprises a first valve for blocking or opening the biological sample channel and a second valve for blocking or opening the reaction liquid injection channel.
    [0010] In an embodiment of the first aspect, the bioreactor device further comprises a metering device for quantifying the biological sample and the reaction liquid to be biologically reacted with the biological sample, and wherein the biological sample-extraction chamber, the metering device, and the reaction chamber are in fluid communication with each other.
    [0011] In an embodiment of the first aspect, the metering device comprises one or more of the followings: a metering chamber, a microfluidic or nanofluidic chip, or a microfluidic or nanofluidic capillary.
    [0012] In an embodiment of the first aspect, the bioreactor device further comprises a mixing driver fixed above the microfluidic or nanofluidic structure, and the mixing driver comprises a mixing nozzle extending through the microfluidic or nanofluidic structure and inserting into the liquid level in the biological sample-extraction chamber.
    [0013] In an embodiment of the first aspect, the bioreactor device further comprises at least one reaction liquid storing tank for storing the reaction liquid, and the reaction liquid storing tank is disposed above the microfluidic or nanofluidic structure and in fluid communication with the reaction chamber through the reaction liquid injection channel.
    [0014] In an embodiment of the first aspect, the bioreactor device further includes a decompression device, a decompression channel, and a third valve, wherein the decompression device and the decompression channel are disposed above the microfluidic or nanofluidic the structure, the decompression device is in fluid communication with the reaction chamber through the decompression channel, and the third valve is used for blocking or opening the decompression channel.
    [0015] In an embodiment of the first aspect, the first valve, the second valve, and the third valve are integrated into one press-type valve. When the valve button on the press-type valve is pressed, the channel of the press-type valve is in communication with the biological sample channel. As a result, the biological sample channel is opened, while the reaction liquid injection channel and the decompression channel are closed. When the valve button on the press-type valve is pulled up, the channel of the valve is deviated from the biological sample channel. As a result, the biological sample channel is closed and the reaction liquid injection channel and the decompression channel are opened, resulting in the opening of the decompression channel.
    [0016] In an embodiment of the first aspect, the biological sample-extraction chamber contains magnetic beads which adsorb macromolecular extracts including nucleic acid or protein.
    [0017] In an embodiment of the first aspect, the biological sample-extraction chamber further comprises an electromagnet which adsorb the magnetic beads in the biological sample-extraction chamber, wherein the electromagnet is disposed outside the biological sample-extraction chamber on the side away from the liquid delivery tip.
    [0018] In an embodiment of the first aspect, when the materials in the biological sample-extraction chamber are mixed, the electromagnet is in a non-energized state, and the magnetic beads are dispersed in the biological sample-extraction chamber; when the metering chamber, the electromagnet is energized and the magnetic beads are attracted to the side away from the liquid delivery tip.
    [0019] In an embodiment of the first aspect, the decompression device is a decompression pump which includes a piston push-pull structure.
    [0020] In an embodiment of the first aspect, the reaction liquid storing tank comprises a piston push-pull structure, wherein the piston push-pull structure is provided with a puncture structure, and a cavity for accommodating the reaction liquid is formed in the reaction liquid storing tank with an encapsulation film in the cavity bottom.
    [0021] In an embodiment of the first aspect, the biological sample-extraction chamber and the reaction chamber are both removable structures.
    [0022] In an embodiment of the first aspect, the biological sample-extraction chamber and the reaction chamber are fixed to the main structure of the bioreactor device equipped with the microfluidic or nanofluidic structure by ways of buckle or screw thread.
    [0023] In an embodiment of the first aspect, the microfluidic or nanofluidic structure comprises a positioning via that enables fluid joining and connection.
    [0024] Compared with the prior art, the beneficial effects of the present application are that the bioreactor device of the present application is equipped with the microfluidic or nanofluidic structure, wherein the microfluidic or nanofluidic structure is provided to connect the biological sample-extraction chamber, the metering chamber and the reaction chamber. In addition, the biological sample (e.g., protein, nucleic acid) in the biological sample-extraction chamber is accurately quantified by the microfluidic or nanofluidic structure, and sufficiently and efficiently transferred to the reaction chamber. Therefore, the experimental processes are simplified, and the experimental efficiency is improved. Furthermore, when the biological sample is transferred, the risk of contamination is reduced. In particular, the mixing driver is disposed on the bioreactor device of the present application which is equipped with the microfluidic or nanofluidic structure. By pushing and pulling the mixing driver, the materials in the biological sample-extraction chamber are mixed and stirred, facilitating fully eluting of the extract adsorbed around the magnetic beads. In addition, a metering pump is disposed on the bioreactor device of the present application. When the metering pump is pumped backward, the negative pressure generated in the metering pump forces the biological sample in the biological sample-extraction chamber into the metering pump through the liquid delivery tip, the biological sample channel, and the metering chamber. The reaction liquid injection channel is in fluid communication with the reaction chamber via the metering chamber. The reaction liquid in the reaction liquid storing tank is injected into the reaction chamber via the reaction liquid injection channel and the metering chamber. As a result, the biological sample (e.g., protein, nucleic acid) is sufficiently and efficiently transferred from the biological sample-extraction chamber to the reaction chamber. Therefore, the experimental processes are simplified, and the experimental efficiency is improved. Furthermore, when the biological sample is transferred, the risk of contamination is reduced.
    [0025] In addition, the bioreactor device of the present invention, which is equipped with the microfluidic or nanofluidic structure, has a simple overall structure and is easy to operate. The devices disposed in the bioreactor device of the present invention, including the microfluidic or nanofluidic structure, the press-type valve, the removable chamber for biological sample extraction and the reaction chamber, the piston-type reaction liquid storing tank, the mixing driver, the metering pump and the like, are all able to collaborate very well with external automation devices, especially the pressing device or push-pull device with a cylinder or driving mechanism. Furthermore, the related external devices for implementing such simple actions are greatly simplified, thereby effectively simplifying the devices used with the bioreactor device of the present invention. BRIEF DESCRIPTION OF THE DRAWINGS
    [0026] Figure 1 is a schematic diagram of a bioreactor device equipped with a microfluidic or nanofluidic structure according to a preferred embodiment of the present invention. Figure 2 is another schematic diagram of a bioreactor device equipped with a microfluidic or nanofluidic structure according to a preferred embodiment of the present invention. Figure 3 is a schematic diagram of a microfluidic or nanofluidic structure in a bioreactor device equipped with a microfluidic or nanofluidic structure according to a preferred embodiment of the present invention. In figure 3, the hollow arrow indicates the flow direction of the biological sample, and the solid arrow indicates the flow direction of the reaction liquid. Figure 4 is a cross-sectional view of the valve region in Figure 2. Figure 5 is another schematic diagram of a bioreactor device equipped with a microfluidic or nanofluidic structure according to a preferred embodiment of the present invention. Figure 6 is a further schematic diagram of a bioreactor device equipped with a microfluidic or nanofluidic structure according to a preferred embodiment of the present invention.DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
    [0027] The technical solutions of the present application will be clearly and completely described in the following with reference to the accompanying drawings and embodiments of the present application.
    [0028] Embodiments of the present invention provide a bioreactor device equipped with a microfluidic or nanofluidic structure, which comprises a biological sample-extraction chamber, a metering chamber, a reaction chamber, and a microfluidic or nanofluidic structure for transferring a macromolecular extract in the biological sample-extraction chamber to the reaction chamber. A mixing driver, disposed above the microfluidic or nanofluidic structure, is fixed to the microfluidic or nanofluidic structure. In addition, the mixing driver has a mixing nozzle extending through the microfluidic or nanofluidic structure and inserting into the liquid level in the biological sample-extraction chamber. By pulling and pushing the mixing driver, the materials in the biological sample-extraction chamber are mixed. Furthermore, a metering pump is disposed above the microfluidic or nanofluidic structure, and a metering chamber is disposed in the microfluidic or nanofluidic structure. The microfluidic or nanofluidic structure further comprises a biological sample channel to connect the biological sample-extraction chamber and the metering chamber. The other end of the biological sample channel is in fluid communication with the liquid delivery tip disposed in the biological sample-extraction chamber. The other end of the metering chamber is in fluid communication with the channel of the metering pump. When the metering pump is pumped backward, the negative pressure generated in the metering pump forces the biological sample in the biological sample-extraction chamber into the metering pump through the liquid delivery tip, the biological sample channel, and the metering chamber. In addition, a reaction liquid storing tank is disposed above the microfluidic or nanofluidic structure. The microfluidic or nanofluidic structure further comprises reaction liquid injection channels which is in fluid communication with the reaction chamber via the metering chamber. Before the reaction starts in the reaction chamber, the reaction liquid in the reaction liquid storing tank is injected into the reaction chamber via the metering chamber through the reaction liquid injection channel. Then, the reaction liquid is mixed and reacted with the biological sample obtained from the biological sample-extraction chamber and transferred to the reaction chamber. Moreover, a decompression pump is disposed above the microfluidic or nanofluidic structure, and a decompression channel is disposed above the microfluidic or nanofluidic structure, wherein the decompression pump is in fluid communication with the reaction chamber through the decompression channel. Before the reaction liquid is injected into the reaction chamber, the decompression pump is pumped backward, and the reaction chamber generates a negative pressure so that the reaction liquid is smoothly injected into the reaction chamber.
    [0029] In one embodiment, a liquid valve capable of blocking or opening the biological sample channel is disposed above the microfluidic or nanofluidic structure, wherein the valve is capable of blocking or opening the decompression channel and the decompression channel. In a preferred embodiment of the present invention, the valve is a press-type valve. After a single press of the valve button on the valve, the channel of the valve is in fluid communication with the biological sample channel so that the biological sample channel is opened. Meanwhile, the reaction liquid injection channel and the decompression channel are closed. After the valve button on the valve is pulled up, the channel of the valve is deviated from the biological sample channel so that the biological sample channel is closed. At the same time, the reaction liquid injection channel is in fluid communication with the channel of the valve so that the reaction liquid injection channel is opened. Furthermore, the decompression channel is also in fluid communication with the channel of the valve so that the decompression channel is opened.
    [0030] In one embodiment, the biological sample-extraction chamber contains magnetic beads that adsorb macromolecular extracts including nucleic acid or protein.
    [0031] In one embodiment, the biological sample-extraction chamber further comprises an electromagnet to adsorb the magnetic beads in the biological sample-extraction chamber, wherein the electromagnet is disposed outside at the side away from the liquid delivery tip. When the materials in the biological sample-extraction chamber are mixed, the electromagnet is in a non-energized state, and the magnetic beads are dispersed in the biological sample-extraction chamber. The materials in the biological sample-extraction chamber are mixed by pushing and pulling the mixing driver, which facilitates the efficient elution of the extract adsorbed to the magnetic beads in the biological sample-extraction chamber. When the extract is efficiently eluted and the biological sample is needed to be transferred from the biological sample-extraction chamber to the metering chamber, the electromagnet is energized and the magnetic beads are attracted to the side away from the liquid delivery tip.
    [0032] In one embodiment, one or two or more reaction liquid storing tanks are provided. In a preferred embodiment of the invention, in one embodiment of the invention, there are two the reaction liquid storing tanks.
    [0033] In one embodiment, the metering chamber may be a buckle-type replaceable structure.
    [0034] In one embodiment, the decompression pump includes a piston push-pull structure. Before the reaction liquid is needed to be injected into the reaction chamber, the piston is pumped backward. As a result, a negative pressure is generated in the reaction chamber so that the reaction liquid is smoothly injected into the reaction chamber.
    [0035] In one embodiment, the reaction liquid storing tank comprises a piston push-pull structure, wherein the piston push-pull structure is provided with a puncture structure. A cavity for accommodating the reaction liquid is formed in the reaction liquid storing tank with an encapsulation film in the cavity bottom. When the reaction liquid is needed to be injected into the reaction chamber, the piston push-pull structure is pushed. Then, the puncture structure pierces the encapsulation film at the bottom of the cavity, and the reaction liquid is injected into the reaction chamber through the reaction liquid injection channel.
    [0036] In one embodiment, the biological sample-extraction chamber and the reaction chamber are both removable structures.
    [0037] In one embodiment, the biological sample-extraction chamber and the reaction chamber are fixed to the main structure of the bioreactor device equipped with the microfluidic or nanofluidic structure by ways of buckle or screw thread.
    [0038] The technical solutions in the embodiments of the present invention are clearly and completely described in the following with reference to the accompanying drawings in the embodiments of the present invention. It is obvious that the described embodiments are only part of the embodiments of the present invention, but do not form all embodiments of the present invention. All other embodiments, obtained by those skilled in the art based on the embodiments of the present invention without inventive efforts, are in the scope of the present invention.
    [0039] Figures 1 and 2 are schematic diagrams showing the structure of a bioreactor device equipped with a microfluidic or nanofluidic structure according to a preferred embodiment of the present invention. The bioreactor device equipped with the microfluidic or nanofluidic structure is applied to devices used for the preparation and detection of nucleic acid or protein. The bioreactor device aims to, but not limited to, provide an efficient and rapid solution for material transfer between adjacent steps in obtaining and subsequent detecting the nucleic acid or protein samples. In practical applications, the extraction cartridge can also be used to extract other biological extracts.
    [0040] As shown in Figures 1-4, a bioreactor device 30 equipped with a microfluidic or nanofluidic structure provided by a preferred embodiment of the present invention includes a biological sample-extraction chamber 10, a metering chamber 18, a reaction chamber 20, and a microfluidic or nanofluidic structure 30 for transferring macromolecular extracts from the biological sample-extraction chamber 10 to the reaction chamber 20. A mixing driver 40 is disposed above and secured to the microfluidic or nanofluidic structure 30. The mixing driver 40 is provided with a mixing nozzle 41 extending through the microfluidic or nanofluidic structure 30 and inserting into the liquid level in the biological sample-extraction chamber 10. By pushing and pulling the mixing driver 40, materials in the biological sample-extraction chamber 10 are mixed.
    [0041] Furthermore, a metering pump 50 is disposed above the microfluidic or nanofluidic structure 30, and a metering chamber 18 is disposed in the microfluidic or nanofluidic structure. In addition, the microfluidic or nanofluidic structure 30 comprises a biological sample channel 32 connecting the biological sample-extraction chamber 10 and the metering chamber 18. One end of the biological sample channel 32 is in fluid communication with a liquid delivery tip 51 disposed in the biological sample-extraction chamber 10. The other end of the metering chamber 18 is in fluid communication with the biological sample channel 32 of the metering pump 50. When the metering pump is pumped backward (i.e., a piston of the metering pump is pulled upward), the negative pressure generated by the metering pump 50 forces the biological samples in the biological sample-extraction chamber 10 to enter the metering chamber 18 through the liquid delivery tip 51 and the biological sample channel 32.
    [0042] In another particular embodiment, referring to Figures 5 and 6, the metering device may be configured as a microfluidic or nanofluidic chip 181 or a microfluidic or nanofluidic capillary.
    [0043] In addition, a reaction liquid storing tank 70 is disposed above the microfluidic or nanofluidic structure 30. Furthermore, a reaction liquid injection channel 33 is disposed in the microfluidic or nanofluidic structure 30. The reaction liquid injection channel 33 is in fluid communication with the reaction chamber 20 via the metering chamber 18. Before the reaction starts in the reaction chamber 20, the reaction liquid in the reaction liquid storing tank 70 is injected into the reaction chamber 20 through the reaction liquid injection channel 33 and the metering chamber 18, so as to be mixed and reacted with the biological samples obtained from the biological sample-extraction chamber 10 and transferred to the reaction chamber 20.
    [0044] In addition, a decompression pump 80 with a decompression piston 82 therein are disposed above the microfluidic or nanofluidic structure 30. A decompression channel 34 is also disposed above the microfluidic or nanofluidic structure 30. The decompression pump 80 is in fluid communication with the reaction chamber 20 through the decompression channel 34. Before the reaction liquid is injected into the reaction chamber 20, the decompression piston 82 in the decompression pump 80 is pumped backward. Consequently, the reaction chamber 20 generates a negative pressure so that the reaction liquid is smoothly injected into the reaction chamber 20.
    [0045] In a preferred embodiment of the invention, the microfluidic or nanofluidic structure 30 is further provided with a liquid valve 60 capable of blocking or opening the decompression channel 34. In addition, the valve 60 is capable of blocking or opening the reaction liquid injection channel 33. Specifically, the valve 60 is a press-type valve 60. After pressing the valve button 61 on the valve 60, the channel of the valve 62 is in fluid communication with the biological sample channel 32, and the biological sample channel 32 is opened. Meanwhile, the reaction liquid injection channel 33 and the pressure-reducing channel 34 are closed. After pulling up the valve button 61 on the valve 60, the channel of the valve 62 is deviated from the biological sample channel 32, and the biological sample channel 32 is closed. Meanwhile, the reaction liquid injection channel 33 and the pressure reduction channel 34 are opened.
    [0046] In a specific embodiment, the biological sample channel has a width of 0. 55 to 0. 75 mm, a depth of 0. 50 to 0. 65 mm, and a length of 8 to 12 mm. In a preferred embodiment, the biological sample channel has a width of 0. 65 mm, a depth of 0.6 mm, and a length of 12 mm.
    [0047] In a specific embodiment, the reaction liquid channel has a width of 0. 55 to 0. 75 mm, a depth of 0. 50 to 0. 65 mm, and a length of 8 to 12 mm. In a preferred embodiment, the reaction liquid channel has a width of 0. 65 mm, a depth of 0.6 mm, and a length of 12 mm.
    [0048] In a preferred embodiment of the invention, the biological sample-extraction chamber 10 contains magnetic beads which can adsorb macromolecular extracts including nucleic acid or protein.
    [0049] In addition, the biological sample-extraction chamber 10 further comprises an electromagnet for adsorbing the magnetic beads in the biological sample-extraction chamber 10, wherein the electromagnet is disposed outside the biological sample-extraction chamber 10 on the side away from the liquid delivery tip 51. The materials in the biological sample-extraction chamber 10 are mixed by pushing and pulling the mixing driver 40, to facilitate the efficient elution of the extracts adsorbed by the magnetic beads in the biological sample-extraction chamber 10, the electromagnet is in a non-energized state, and the magnetic beads are dispersed in the biological sample-extraction chamber 10. When the biological sample is required to be transferred from the biological sample-extraction chamber 10 to the metering chamber 18 for the efficient elution of the extracts, the electromagnet is energized and the magnetic beads are attracted to the side away from the liquid delivery tip 51. In addition, the biological sample (e.g., protein, nucleic acid) in the biological sample-extraction chamber 10 is accurately quantified and efficiently transferred to the reaction chamber 20 in total by the microfluidic or nanofluidic structure 30. Thereby, the magnetic beads and other impurities are prevented to be transferred together with the biological sample (e.g., protein, nucleic acid) while it is fully and efficiently transferred from the biological sample-extraction chamber 10 to the reaction chamber 20.
    [0050] As a preferred embodiment of the present invention, in the embodiment of the present invention, two reaction liquid storing tanks 70 are provided. Certainly, in other embodiments of the present invention, one or other number of reaction liquid storing tanks 70 are provided, as long as the corresponding biochemical reaction in the reaction chamber of the present invention could be carried out.
    [0051] In addition, in the embodiment of the present invention, the reaction liquid storing tank 70 includes a piston push-pull structure 71, wherein the piston push-pull structure 71 is provided with a puncture structure 73. A cavity for accommodating the reaction liquid is formed in the reaction liquid storing tank 70, and the bottom of the cavity is an encapsulation film 72. When it is required to inject the reaction liquid into the reaction chamber 20, the piston push-pull structure 71 is pushed. Consequently, the puncture structure 73 pierces the encapsulation film 72 at the bottom of the cavity, and the reaction liquid is injected into the reaction chamber 20 through the reaction liquid injection channel 33 and the metering chamber 18.
    [0052] The biological sample-extraction chamber 10 and the reaction chamber 20 in the embodiment of the present invention are both removable structures, so as to facilitate installment and replacement. In a specific embodiment, the biological sample-extraction chamber 10 and the reaction chamber 20 are secured to the main structure of the bioreactor device equipped with a microfluidic or nanofluidic structure by means of screw thread 23. Certainly, in other embodiments of the present invention, the biological sample-extraction chamber 10 and the reaction chamber 20 may be fixed to the main structure of the bioreactor device by buckles or other commonly used removable fixing means.
    [0053] In embodiments of the present invention, in order to scientifically arrange the microfluidic or nanofluidic structure 30 and other corresponding structures to achieve good connection and engagement of fluid flows, positioning regions and connecting micropores are disposed on the microfluidic or nanofluidic structure 30 for the related structures. so as The mixing driver 40 is fixed to the microfluidic or nanofluidic structure 30 and has a mixing nozzle 41 extending through the microfluidic or nanofluidic structure 30 and inserting into the liquid level in the biological sample-extraction chamber 10. A positioning hole 410 corresponds to the mixing driver 40. The liquid delivery tip 51, installed below the liquid level in the biological sample-extraction chamber 10 of the microfluidic or nanofluidic structure 30, is in fluid communication with the biological sample channel 32 and a valve chamber 90 through the positioning hole 450. After the pressure generated by the metering pump 50 applied to the biological samples in the biological sample-extraction chamber 10, the biological samples flow outward to the biological sample channel 32 through the liquid delivery tip 51 and then enter into the metering chamber 18. The biological sample channel 32 is in fluid communication with a liquid conduit 21 through the valve liquid-guiding port 45. The metering pump 50 is in fluid communication with the biological sample channel 32 by a positioning hole 500.
    [0054] Before a reaction starts in the reaction chamber 20, a decompression chamber 80 installed in the microfluidic or nanofluidic structure 30 is in fluid communication with the reaction chamber 20 through a micropore 680, the decompression channels 34, and a decompression hole 68 on the valve 60. After the reaction chamber 20 is depressurized by the decompression piston 82 in the decompression chamber 80, a reaction liquid in the reaction liquid storing tank 70 is injected into the reaction chamber 20 through the reaction liquid injection channel 33, the metering chamber 18, and the liquid conduit 21. A micropore 700 is used to connect the reaction liquid injection channel 33, the metering chamber 18, and the liquid conduit 21.
    [0055] The bioreactor device disclosed in the above embodiments is equipped with the microfluidic or nanofluidic structure, wherein the microfluidic or nanofluidic structure is provided to connect the biological sample-extraction chamber, the metering chamber and the reaction chamber. In addition, the biological sample (e.g., protein, nucleic acid) in the biological sample-extraction chamber is accurately quantified by the microfluidic or nanofluidic structure, and sufficiently and efficiently transferred to the reaction chamber. Therefore, the experimental processes are simplified, and the experimental efficiency is improved. Furthermore, when the biological sample is transferred, the risk of contamination is reduced. In particular, the mixing driver is disposed on the bioreactor device of the present application which is equipped with a microfluidic or nanofluidic structure. By pushing and pulling the mixing driver, the materials in the biological sample-extraction chamber are mixed and stirred, facilitating fully eluting of the extract adsorbed around the magnetic beads. In addition, the metering pump is disposed on the bioreactor device of the present application. When the metering pump is pumped backward, the negative pressure generated in the metering pump forces the biological sample in the biological sample-extraction chamber into the metering pump through the liquid delivery tip, the biological sample channel, and the metering chamber. The reaction liquid injection channel is in fluid communication with the reaction chamber via the metering chamber. The reaction liquid in the reaction liquid storing tank is injected into the reaction chamber via the reaction liquid injection channel and the metering chamber. As a result, the biological sample (e.g., protein, nucleic acid) is sufficiently and efficiently transferred from the biological sample-extraction chamber to the reaction chamber. Therefore, the experimental processes are simplified, and the experimental efficiency is improved. Furthermore, when the biological sample is transferred, the risk of contamination is reduced.
    [0056] In addition, the bioreactor device of the present invention, which is equipped with the microfluidic or nanofluidic structure, has a simple structure and is easy to operate. The devices disposed in the bioreactor device of the present invention, including the microfluidic or nanofluidic structure, the press-type valve, the removable chamber for biological sample extraction and the reaction chamber, the piston-type reaction liquid storing tank, the mixing driver, the quantification pump and the like, are all able to collaborate very well with external automation devices, especially the pressing device or push-pull device with a cylinder or driving mechanism. Furthermore, the related external devices for implementing such simple actions are greatly simplified, thereby effectively simplifying the devices used with the bioreactor device of the present invention.
    [0057] The above description of the embodiments is provided to facilitate the understanding and application of the present application by those skilled in the art. It will be obvious to those skilled in the art that various modifications may be made to these embodiments and the general principles described herein may be applied to other embodiments without departing from the scope of the invention. Therefore, the present application is not limited to the embodiments herein, and those skilled in the art can make modifications and changes in the scope of the present application without departing from the scope and spirit of the invention.
    权利要求:
    Claims (15)
    [0001] A bioreactor device equipped with a microfluidic or nanofluidic structure, comprising:
    a biological sample-extraction chamber for providing a biological sample to participate in a biological reaction, and comprising a liquid delivery tip disposed in the biological sample-extraction chamber;
    a reaction chamber for causing the biological sample biologically react with a reaction liquid to be biologically reacted with the biological sample;
    a microfluidic or nanofluidic structure for transferring the biological sample from the biological sample-extraction chamber to the reaction chamber;
    wherein the microfluidic or nanofluidic structure comprises a biological sample channel and a reaction liquid injection channel;
    wherein the biological sample-extraction chamber and the reaction chamber are in fluid communication with each other via the biological sample channel, and the reaction liquid is injected into the reaction chamber through the reaction liquid injection channel;
    wherein the microfluidic or nanofluidic structure further comprises a first valve for blocking or opening the biological sample channel and a second valve for blocking or opening the reaction liquid injection channel.
    [0002] The bioreactor device equipped with a microfluidic or nanofluidic structure of claim 1, wherein the bioreactor device further comprises a metering device for quantifying the biological sample and the reaction liquid to be biologically reacted with the biological sample, and wherein the biological sample-extraction chamber, the metering device, and the reaction chamber are in fluid communication with each other.
    [0003] The bioreactor device equipped with a microfluidic or nanofluidic structure of claim 2, wherein the metering device comprises one or more of the followings: a metering chamber, a microfluidic or nanofluidic chip, or a microfluidic or nanofluidic capillary.
    [0004] The bioreactor device equipped with a microfluidic or nanofluidic structure of claim 1, wherein the bioreactor device further comprises a mixing driver, and wherein the mixing driver is fixed above the microfluidic or nanofluidic structure, and comprises a mixing nozzle extending through the microfluidic or nanofluidic structure and inserting into the liquid level in the biological sample-extraction chamber.
    [0005] The bioreactor device equipped with a microfluidic or nanofluidic structure of claim 1, wherein the bioreactor device further comprises at least one reaction liquid storing tank for storing the reaction liquid, and wherein the reaction liquid storing tank is disposed above the microfluidic or nanofluidic structure and in fluid communication with the reaction chamber through the reaction liquid injection channel.
    [0006] The bioreactor device equipped with a microfluidic or nanofluidic structure of claim 1, wherein the bioreactor device further includes a decompression device, a decompression channel, and a third valve; wherein the decompression device and the decompression channel are disposed above the microfluidic or nanofluidic structure; wherein the decompression device is in fluid communication with the reaction chamber through the decompression channel; and wherein the third valve is used for blocking or opening the decompression channel.
    [0007] The bioreactor device equipped with a microfluidic or nanofluidic structure of claim 6, wherein the first valve, the second valve, and the third valve are integrated into one press-type valve; wherein when the valve button on the press-type valve is pressed, the channel of the press-type valve is in fluid communication with the biological sample channel with the biological sample channel being opened while the reaction liquid injection channel and the decompression channel being closed; and when the valve button on the press-type valve is pulled up, the channel of the valve is deviated from the biological sample channel, the biological sample channel is closed while the reaction liquid injection channel and the pressure reduction channel are opened.
    [0008] The bioreactor device equipped with a microfluidic or nanofluidic structure of claim 1, wherein the biological sample-extraction chamber contains magnetic beads which adsorb macromolecular extracts including nucleic acid or protein.
    [0009] The bioreactor device equipped with a microfluidic or nanofluidic structure of claim 8, wherein the biological sample-extraction chamber further comprises an electromagnet to adsorb the magnetic beads in the biological sample-extraction chamber, and wherein the electromagnet is disposed outside the biological sample-extraction chamber on the side away from the liquid delivery tip.
    [0010] The bioreactor device equipped with a microfluidic or nanofluidic structure of claim 9, wherein when the materials in the biological sample-extraction chamber are mixed, the electromagnet is in a non-energized state, and the magnetic beads are dispersed in the biological sample-extraction chamber; and wherein when the metering chamber, the electromagnet is energized and the magnetic beads are attracted to the side away from the liquid delivery tip.
    [0011] The bioreactor device equipped with a microfluidic or nanofluidic structure of claim 6, wherein the decompression device is a decompression pump which includes a piston push-pull structure.
    [0012] The bioreactor device equipped with a microfluidic or nanofluidic structure of claim 5, wherein the reaction liquid storing tank comprises a piston push-pull structure, and wherein the piston push-pull structure is provided with a puncture structure, and a cavity for accommodating the reaction liquid is formed in the reaction liquid storing tank with an encapsulation film in the cavity bottom.
    [0013] The bioreactor device equipped with a microfluidic or nanofluidic structure of claim 1, wherein the biological sample-extraction chamber and the reaction chamber are both removable structures.
    [0014] The bioreactor device equipped with a microfluidic or nanofluidic structure of claim 13, wherein the biological sample-extraction chamber and the reaction chamber are fixed to the main structure of the bioreactor device equipped with a microfluidic or nanofluidic structure by ways of buckle or screw thread.
    [0015] The bioreactor device equipped with a microfluidic or nanofluidic structure of claim 1, wherein the microfluidic or nanofluidic structure comprises a positioning via that enables fluid joining and connection.
    类似技术:
    公开号 | 公开日 | 专利标题
    JP6698786B2|2020-05-27|Single-Structure Biochip and Manufacturing Method Providing Process from Sample Introduction to Results Output
    US10682647B2|2020-06-16|Microfluidic system with fluid pickups
    US20200108388A1|2020-04-09|Sample preparation, processing and analysis systems
    US9182322B2|2015-11-10|Microfluidic mixing and reaction systems for high efficiency screening
    US10525469B2|2020-01-07|Devices and methods for molecular diagnostic testing
    US10022722B2|2018-07-17|Sample vessels
    US10040061B2|2018-08-07|System and apparatus for reactions
    CN105026932B|2017-06-13|Micro-fluidic distributing equipment
    US9012236B2|2015-04-21|Universal sample preparation system and use in an integrated analysis system
    JP2020042050A|2020-03-19|Test cartridge with integrated transfer module
    US8894946B2|2014-11-25|Sample preparation, processing and analysis systems
    US7867773B2|2011-01-11|Method of holding a slide cassette for fluidic injection
    US7998437B2|2011-08-16|Microfluidic assembly with coupled microfluidic devices
    EP1883474B1|2021-03-31|System for the integrated and automated analysis of dna or protein and method for operating said type of system
    US8088576B2|2012-01-03|Method and assembly for DNA isolation with dry reagents
    US8748165B2|2014-06-10|Methods for generating short tandem repeat | profiles
    JP5337912B2|2013-11-06|Sheath flow apparatus and method
    US20200264205A1|2020-08-20|Methods and devices for analysis of defined multicellular combinations
    AU2014356426B2|2020-02-13|Microfluidic cartridge for molecular diagnosis, docking station using a microfluidic cartridge, and process for analyzing a biological sample
    JP2016519296A5|2017-10-26|
    EP1343973B1|2017-11-08|Apparatus and methods for conducting assays and high throughput screening
    CN105873681B|2019-10-11|Cartridge and instrument for sample analysis
    US7482153B2|2009-01-27|Nucleic acid detection cassette and nucleic acid detection device
    US20120276532A1|2012-11-01|Sample processing device for pretreatment and thermal cycling
    CN107338189B|2021-02-02|Apparatus and method for integrated sample preparation, reaction and detection
    同族专利:
    公开号 | 公开日
    EP3683297A4|2021-04-28|
    WO2020107641A1|2020-06-04|
    CN109266518A|2019-01-25|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    法律状态:
    2020-02-18| STAA| Information on the status of an ep patent application or granted ep patent|Free format text: STATUS: UNKNOWN |
    2020-06-06| STAA| Information on the status of an ep patent application or granted ep patent|Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
    2020-06-19| STAA| Information on the status of an ep patent application or granted ep patent|Free format text: STATUS: THE APPLICATION HAS BEEN PUBLISHED |
    2020-06-19| PUAI| Public reference made under article 153(3) epc to a published international application that has entered the european phase|Free format text: ORIGINAL CODE: 0009012 |
    2020-07-22| AX| Request for extension of the european patent|Extension state: BA ME |
    2020-07-22| AK| Designated contracting states|Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
    2020-12-04| STAA| Information on the status of an ep patent application or granted ep patent|Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
    2021-01-06| RBV| Designated contracting states (corrected)|Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
    2021-01-06| 17P| Request for examination filed|Effective date: 20201127 |
    2021-04-28| RIC1| Information provided on ipc code assigned before grant|Ipc: C12M1/00 20060101AFI20210319BHEP Ipc: G01N 35/10 20060101ALI20210319BHEP Ipc: C12M3/06 20060101ALI20210319BHEP |
    2021-04-28| A4| Supplementary search report drawn up and despatched|Effective date: 20210325 |
    2021-11-05| STAA| Information on the status of an ep patent application or granted ep patent|Free format text: STATUS: EXAMINATION IS IN PROGRESS |
    2021-12-08| 17Q| First examination report despatched|Effective date: 20211104 |
    优先权:
    申请号 | 申请日 | 专利标题
    [返回顶部]